View More Recent Stories
-
Protagonist Therapeutics (PTGX) PT Raised to $51 at BTIG
-
Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024
-
These are BTIG's top pick stocks for H2 2024
-
Protagonist Therapeutics (PTGX) to Join S&P SmallCap 600
-
H.C. Wainwright Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
-
Protagonist Therapeutics (PTGX) PT Raised to $39 at JPMorgan

